Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P.E., Zhou, X., Li, C., Shen, G., Zou, Bingwen, NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential, Signal Transduction and Targeted Therapy
Contraindications and Precautions Consider avoiding BPC-157 if you have: History of cancer or active malignancy Pregnancy or breastfeeding (no safety data) Competitive athletic status (WADA prohibits peptides) Known sensitivity to peptide products Severe cardiovascular disease (limited data) Blood pressure monitoring may be prudent given the nitric oxide modulation effects
On July 23 and 24, 2026, the committee recommended inclusion of specified free-base and acetate forms related to BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax
The association becomes stronger at higher levels, with severe hyperhomocysteinaemia (above about 30 mol/L) showing a clearer relationship with clotting risk than mild elevations in the 15-30 mol/L range (5)
In the context of wound healing, peptides are increasingly seen as promising agents for improving outcomes in both chronic and acute wounds due to their versatility, targeted mechanisms, and low immunogenicity